Tuberculosis
Infectious diseaseno solution listed yet
Tuberculosis: the world is 77% of the way short of its target (WHO End TB: 80% lower than 2015).
Key messages
- Size of the gap: 131 new cases per 100,000 (2024); target 30 (WHO End TB: 80% lower than 2015).
- What can be done: no reviewed solution yet; the loop is searching.
Why it is on the list
Indicator SH.TBS.INCD (World Bank): 131 new cases per 100,000 (2024); target 30 (WHO End TB: 80% lower than 2015). Gap to target: 77%. Rank 1 of 11. Source data
Solutions
No reviewed solution is listed yet. The loop searches the literature for this problem every cycle; any lead it finds appears below.
Leads found by the loop
Sentences quoted unchanged from systematic-review abstracts and re-checked by a separate step.
Pulmonary tuberculosis detection For detection of pulmonary tuberculosis, Xpert Ultra summary sensitivity and specificity against culture were 90.7% (95% confidence interval (CI) 88.2 to 92.7) and 94.8% (95% CI 92.8 to 96.3) (32 studies, 12,529 participants; high-certainty evidence).
In people living with HIV, Xpert Ultra summary sensitivity and specificity were 87.7% (82.0 to 91.7) and 95.3% (92.2 to 97.2) (11 studies, 1164 participants).
Xpert Ultra has high sensitivity and specificity for detection of pulmonary tuberculosis rifampicin resistance.
Xpert Ultra for the detection of pulmonary tuberculosis has lower sensitivity in people with smear-negative/culture-positive tuberculosis and lower sensitivity and specificity in people with a history of tuberculosis.
every quoted sentence and number found in the abstract
For the reference standard, the risk of bias for included studies was low (75%) or unclear (25%).
Cerebrospinal fluid Xpert Ultra (16 studies) Xpert Ultra summary sensitivity and specificity (95% CI) against a microbiological reference standard were 88.2% (83.7 to 91.6) (287 participants; high-certainty evidence) and 96.0% (86.8 to 98.9) (1397 participants; moderate-certainty evidence).
LC-aNAATs are helpful in diagnosing extrapulmonary tuberculosis.
Sensitivity varies across different extrapulmonary specimens, while for most specimens specificity is high, the tests rarely yielding a positive result for people without tuberculosis.
every quoted sentence and number found in the abstract
Seventeen studies (74%) took place in countries with a high tuberculosis burden.
Detection of pulmonary tuberculosis (microbiological reference standard) Sputum (11 studies) Xpert Ultra summary sensitivity was 75.3% (95% CI 68.9% to 80.8%; 345 children; moderate-certainty evidence), and specificity was 95.9% (95% CI 92.3% to 97.9%; 2645 children; high-certainty evidence).
Xpert Ultra sensitivity was moderate in sputum, gastric aspirate, and stool specimens.
Nasopharyngeal aspirate had the lowest sensitivity.
every quoted sentence and number found in the abstract
Recent reviews found, not yet reviewed (searched 2026-11-17):
- Impact of rapid nucleic acid amplification tests for tuberculosis on patient outcomes. (2025) · PubMed
- Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. (2025) · PubMed
- Low-complexity automated nucleic acid amplification tests for extrapulmonary tuberculosis and rifampicin resistance in adults and adolescents. (2025) · PubMed
- Xpert MTB/RIF Ultra assay for pulmonary tuberculosis and rifampicin resistance in adults and adolescents. (2025) · PubMed
Bright spots
Better than income predicts by at least 1.25 standard deviations in both 2022-2026 and 2016-2020. Income is the only control; treat each as a lead to investigate, not a finding.
- Burundi: 83 (2024); 1.57 standard deviations better than income predicts now, 1.56 before
- West Bank and Gaza: 0.29 (2024); 1.51 standard deviations better than income predicts now, 1.33 before
- Comoros: 22 (2024); 1.43 standard deviations better than income predicts now, 1.38 before
- Syrian Arab Republic: 23 (2024); 1.34 standard deviations better than income predicts now, 1.41 before
- Niger: 86 (2024); 1.26 standard deviations better than income predicts now, 1.44 before
- Burkina Faso: 57 (2024); 1.31 standard deviations better than income predicts now, 1.33 before
Open questions
- No reviewed solution is listed for "Tuberculosis". Which interventions have randomised or review-level evidence of reducing it?
- What do Burundi, West Bank and Gaza, Comoros do differently? They beat their income-predicted level in two periods.
Use and cite this entry
Practical Solutions. "Tuberculosis". https://ultrastable.org/problems/tb. Accessed 2026-11-17.
This entry as JSON · Report an error or suggest a correction